Toxicity and mutagenic activity of some selected Nigerian plants

A A Sowemimo1, F A Fakoya, I Awopetu

  • 1Department of Pharmacognosy, Obafemi Awolowo University, Ile-Ife, Nigeria.

Insights

This study investigated the toxicity and mutagenic potential of Nigerian plants used for cancer treatment. Several plants showed cytotoxic and mutagenic effects, justifying their traditional use, while others were found to be non-toxic.

Area of Science:

  • Phytochemistry
  • Toxicology
  • Cancer Research

Background:

  • Many African plants are used in traditional cancer management, but their safety and efficacy are often unverified.
  • Scientific investigation into the toxicity and mutagenic potential of these ethnomedicinal plants is crucial.

Purpose of the Study:

  • To evaluate the toxicity and mutagenic potential of selected Nigerian plants used in cancer treatment.
  • To assess the activity of plant extracts using brine shrimp lethality, telomerase inhibition, and chromosomal aberration assays.

Main Methods:

  • Ethanolic extracts of Nigerian plants were tested for toxicity using the brine shrimp lethality assay.
  • Inhibition of telomerase activity was assessed.
  • In vivo chromosomal aberrations in rat lymphocytes were induced and analyzed.

Main Results:

  • Morinda lucida, Nymphaea lotus, and Garcinia kola showed activity across all three assays.
  • Several other plants exhibited toxicity to brine shrimp and induced chromosomal damage.
  • Chenopodium ambrosioides was non-toxic but inhibited telomerase, suggesting potential selectivity.

Conclusions:

  • The study validates the use of eight plants and Chenopodium ambrosioides in Nigerian cancer management, though they may lack selectivity.
  • Most investigated plants, except Chenopodium ambrosioides, demonstrated mutagenic and cytotoxic properties.
  • Further research is needed to understand the varying mechanisms of action for these ethnomedicinal plants.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...